INmune Bio, Inc. (INMB) Earnings
|
Expand Research on INMB
| Next EPS Date | 8/5/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -24.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +0.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/5/26  |
Q226 | N/A | -$0.19 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/7/26 | Q126 | -$0.20 | -$0.27 | +$0.07 | N/A | N/A | N/A |  | | Details | |
| 3/11/26 |
Q425 | N/A | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/2/26 |
Q425 | N/A | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/4/26 |
Q425 | N/A | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/6/26 |
Q425 | N/A | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/9/26 |
Q425 | N/A | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/10/26 |
Q425 | N/A | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A |
